1
|
Naik G, Prabhudesai A, Malali V, Viegas Parab M, Quadros J, Vaidya P, D'Mello E, Arsekar S, Valaulikar R. Implementation of a hub and spoke STEMI Goa project - Initial results, gains and challenges. Indian Heart J 2025; 77:67-72. [PMID: 39947520 DOI: 10.1016/j.ihj.2025.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 02/09/2025] [Accepted: 02/11/2025] [Indexed: 02/18/2025] Open
Abstract
OBJECTIVES To study the impact of a 'hub and spoke' STEMI management programme on delivery of thrombolysis in the state of Goa. METHODS A prospective observational study was conducted to assess the 'hub and spoke' model STEMI programme in the state of Goa. Data was collected using predesigned proformas filled at Primary Health Centres or District Hospitals which served as the spokes. Primary programme efficacy outcomes studied were the proportion of eligible patients of STEMI receiving thrombolysis and the time to thrombolysis. Secondary outcome assessed was in-hospital mortality. RESULTS A total of 2050 number of patients were diagnosed with STEMI between November 2019 and March 2022, of which complete data was available for 1325 patients. After ruling out contraindications, delayed presentations or refusal for treatment, 74.3 % of STEMI patients received thrombolysis. The median window period was 130.83 min with an interquartile range (IQR) of 159.63 min. The median time from presentation to recording ECG was 7.9 (IQR = 11.63) minutes and presentation to cloud diagnosis was 11.78 (IQR = 12.96) minutes. The median time from presentation to administering thrombolysis (Door to Needle time) was 18.48 (IQR = 28.85) minutes. Only 0.22 % patients received inappropriate thrombolysis and the in-hospital mortality was 9.4 %. CONCLUSION A STEMI programme utilizing the existing manpower and primary health care setup improved 'secondary' level of care to patients by providing thrombolysis to a high percentage of patients in quick time. This may serve as a model to improve the outreach of reperfusion therapy in a resource challenged country like India.
Collapse
Affiliation(s)
- Guruprasad Naik
- Department of Cardiology, Goa Medical College, Bambolim, Goa, 403202, India
| | - Amar Prabhudesai
- Department of Cardiology, Goa Medical College, Bambolim, Goa, 403202, India.
| | - Venkatesh Malali
- Department of Cardiology, Goa Medical College, Bambolim, Goa, 403202, India
| | | | - Joel Quadros
- Department of Cardiology, Goa Medical College, Bambolim, Goa, 403202, India
| | - Pankajam Vaidya
- Department of Cardiology, Goa Medical College, Bambolim, Goa, 403202, India
| | | | | | | |
Collapse
|
2
|
Montoy JCC, Shen YC, Brindis RG, Krumholz HM, Hsia RY. Impact of ST-Segment-Elevation Myocardial Infarction Regionalization Programs on the Treatment and Outcomes of Patients Diagnosed With Non-ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc 2021; 10:e016932. [PMID: 33470136 PMCID: PMC7955417 DOI: 10.1161/jaha.120.016932] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Background Many communities have implemented systems of regionalized care to improve access to timely care for patients with ST-segment-elevation myocardial infarction. However, patients who are ultimately diagnosed with non-ST-segment-elevation myocardial infarctions (NSTEMIs) may also be affected, and the impact of regionalization programs on NSTEMI treatment and outcomes is unknown. We set out to determine the effects of ST-segment-elevation myocardial infarction regionalization schemes on treatment and outcomes of patients diagnosed with NSTEMIs. Methods and Results The cohort included all patients receiving care in emergency departments diagnosed with an NSTEMI at all nonfederal hospitals in California from January 1, 2005 to September 30, 2015. Data were analyzed using a difference-in-differences approach. The main outcomes were 1-year mortality and angiography within 3 days of the index admission. A total of 293 589 patients with NSTEMIs received care in regionalized and nonregionalized communities. Over the study period, rates of early angiography increased by 0.5 and mortality decreased by 0.9 percentage points per year among the overall population (95% CI, 0.4-0.6 and -1.0 to -0.8, respectively). Regionalization was not associated with early angiography (-0.5%; 95% CI, -1.1 to 0.1) or death (0.2%; 95% CI, -0.3 to 0.8). Conclusions ST-segment-elevation myocardial infarction regionalization programs were not statistically associated with changes in guideline-recommended early angiography or changes in risk of death for patients with NSTEMI. Increases in the proportion of patients with NSTEMI who underwent guideline-directed angiography and decreases in risk of mortality were accounted for by secular trends unrelated to regionalization policies.
Collapse
Affiliation(s)
| | - Yu-Chu Shen
- Graduate School of Defense Management, Naval Postgraduate School Monterey CA.,National Bureau of Economic Research Cambridge MA
| | - Ralph G Brindis
- Department of Medicine University of California, San Francisco CA.,Philip R. Lee Institute for Health Policy Studies University of California, San Francisco CA
| | - Harlan M Krumholz
- Section of Cardiovascular Medicine Department of Internal Medicine Yale School of Medicine New Haven CT.,Department of Health Policy and Management Yale School of Public Health New Haven CT.,Center for Outcomes Research and Evaluation Yale-New Haven Hospital New Haven CT
| | - Renee Y Hsia
- Department of Emergency Medicine University of California, San Francisco CA.,Philip R. Lee Institute for Health Policy Studies University of California, San Francisco CA
| |
Collapse
|
3
|
Chandrashekhar Y, Alexander T, Mullasari A, Kumbhani DJ, Alam S, Alexanderson E, Bachani D, Wilhelmus Badenhorst JC, Baliga R, Bax JJ, Bhatt DL, Bossone E, Botelho R, Chakraborthy RN, Chazal RA, Dhaliwal RS, Gamra H, Harikrishnan SP, Jeilan M, Kettles DI, Mehta S, Mohanan PP, Kurt Naber C, Naik N, Ntsekhe M, Otieno HA, Pais P, Piñeiro DJ, Prabhakaran D, Reddy KS, Redha M, Roy A, Sharma M, Shor R, Adriaan Snyders F, Weii Chieh Tan J, Valentine CM, Wilson BH, Yusuf S, Narula J. Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries. Circulation 2020; 141:2004-2025. [PMID: 32539609 DOI: 10.1161/circulationaha.119.041297] [Citation(s) in RCA: 67] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The 143 low- and middle-income countries (LMICs) of the world constitute 80% of the world's population or roughly 5.86 billion people with much variation in geography, culture, literacy, financial resources, access to health care, insurance penetration, and healthcare regulation. Unfortunately, their burden of cardiovascular disease in general and acute ST-segment-elevation myocardial infarction (STEMI) in particular is increasing at an unprecedented rate. Compounding the problem, outcomes remain suboptimal because of a lack of awareness and a severe paucity of resources. Guideline-based treatment has dramatically improved the outcomes of STEMI in high-income countries. However, no such focused recommendations exist for LMICs, and the unique challenges in LMICs make directly implementing Western guidelines unfeasible. Thus, structured solutions tailored to their individual, local needs, and resources are a vital need. With this in mind, a multicountry collaboration of investigators interested in LMIC STEMI care have tried to create a consensus document that extracts transferable elements from Western guidelines and couples them with local realities gathered from expert experience. It outlines general operating principles for LMICs focused best practices and is intended to create the broad outlines of implementable, resource-appropriate paradigms for management of STEMI in LMICs. Although this document is focused primarily on governments and organizations involved with improvement in STEMI care in LMICs, it also provides some specific targeted information for the frontline clinicians to allow standardized care pathways and improved outcomes.
Collapse
Affiliation(s)
- Y Chandrashekhar
- Division of Cardiology, University of Minnesota/VA Medical Center, Minneapolis (Y.C.)
| | - Thomas Alexander
- Division of Cardiology, Kovai Medical Center and Hospital, Coimbatore, India (T.A.)
| | - Ajit Mullasari
- Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India (A.M.)
| | - Dharam J Kumbhani
- Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.J.K.)
| | - Samir Alam
- Division of Cardiology, American University of Beirut Medical Center, Lebanon (S.A.)
| | - Erick Alexanderson
- Nuclear Cardiology Department, Instituto Nacional de Cardiología Ignacio Chávez, Universidad Nacional Autonoma de Mexico, Mexico City (E.A.)
| | - Damodar Bachani
- Building Healthy Cities, John Snow India Pvt Ltd, New Delhi (D.B.)
| | | | - Ragavendra Baliga
- Division of Cardiology, Ohio State University Wexner Medical Center, Columbus (R. Baliga)
| | - Jeroen J Bax
- Division of Cardiology, Leiden University Medical Center, The Netherlands (J.J.B.)
| | - Deepak L Bhatt
- Division of Cardiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (D.L.B.)
| | - Eduardo Bossone
- Department of Cardiology and Cardiac Surgery, Azienda Ospedaliera Universitaria, Salerno, Italy (E.B.)
| | - Roberto Botelho
- Triangulo Heart Institute, Uberlândia, Minas Gerais, Brazil (R. Botelho)
| | | | - Richard A Chazal
- Heart and Vascular Institute for Lee Health, Fort Myers, FL (R.A.C.)
| | - Rupinder Singh Dhaliwal
- Division of Non-Communicable Diseases, Indian Council of Medical Research, New Delhi, India (R.S.D., M.S.)
| | - Habib Gamra
- Department of Cardiology, Fattouma Bourguiba University Hospital, Monastir, Tunisia (H.G.)
| | - Sivadasan Pillai Harikrishnan
- Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India (S.P.H.)
| | - Mohamed Jeilan
- Division of Cardiology, Aga Khan University Medical College, Nairobi, Kenya (M.J., H.A.O.)
| | - David Ian Kettles
- Division of Cardiology, St. Dominic's Hospital, East London, South Africa (D.I.K.)
| | | | - Padhinhare P Mohanan
- Department of Cardiology, Westfort Hi-Tech Hospital, Thrissur, Kerala, India (P.P.M.)
| | - Christoph Kurt Naber
- Department of Cardiology, St.-Marien-Hospital, Mülheim an der Ruhr, Germany (C.K.N.)
| | - Nitish Naik
- Department of Cardiology, All India Institute of Medical Sciences, New Delhi (N.N., A.R.)
| | - Mpiko Ntsekhe
- Division of Cardiology, Groote Schuur Hospital, University of Cape Town, South Africa (M.N.)
| | - Harun Argwings Otieno
- Division of Cardiology, Aga Khan University Medical College, Nairobi, Kenya (M.J., H.A.O.)
| | - Prem Pais
- Division of Clinical Trials, St. John's Research Institute, St. John's Medical College, Bangaluru, India (P.P.)
| | | | - Dorairaj Prabhakaran
- Centre for Chronic Disease Control, Public Health Foundation of India, New Delhi (D.P.)
| | | | - Mustafa Redha
- Ministry of Health of the State of Kuwait, Adan Hospital, Kuwait City (M.R.)
| | - Ambuj Roy
- Department of Cardiology, All India Institute of Medical Sciences, New Delhi (N.N., A.R.)
| | - Meenakshi Sharma
- Division of Non-Communicable Diseases, Indian Council of Medical Research, New Delhi, India (R.S.D., M.S.)
| | - Robert Shor
- Virginia Heart, Inova Alexandria Hospital, Alexandria (R.S.)
| | | | | | | | | | - Salim Yusuf
- Population Health Research Institute, McMaster University School of Medicine, Hamilton, ON, Canada (S.Y.)
| | - Jagat Narula
- Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York (J.N.)
| |
Collapse
|
4
|
Pharmacoinvasive Approach with Streptokinase in Low to Intermediate Risk ST-Elevation Myocardial Infarction Patients: Insights from the Tamil Nadu-STEMI Initiative. Am J Cardiovasc Drugs 2019; 19:517-519. [PMID: 30798503 DOI: 10.1007/s40256-019-00327-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
5
|
Alexander T, Mullasari AS, Joseph G, Kannan K, Veerasekar G, Victor SM, Ayers C, Thomson VS, Subban V, Gnanaraj JP, Narula J, Kumbhani DJ, Nallamothu BK. A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program. JAMA Cardiol 2019; 2:498-505. [PMID: 28273293 DOI: 10.1001/jamacardio.2016.5977] [Citation(s) in RCA: 67] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Importance Challenges to improving ST-segment elevation myocardial infarction (STEMI) care are formidable in low- to middle-income countries because of several system-level factors. Objective To examine access to reperfusion and percutaneous coronary intervention (PCI) during STEMI using a hub-and-spoke model. Design, Setting, and Participants This multicenter, prospective, observational study of a quality improvement program studied 2420 patients 20 years or older with symptoms or signs consistent with STEMI at primary care clinics, small hospitals, and PCI hospitals in the southern state of Tamil Nadu in India. Data were collected from the 4 clusters before implementation of the program (preimplementation data). We required a minimum of 12 weeks for the preimplementation data with the period extending from August 7, 2012, through January 5, 2013. The program was then implemented in a sequential manner across the 4 clusters, and data were collected in the same manner (postimplementation data) from June 12, 2013, through June 24, 2014, for a mean 32-week period. Exposures Creation of an integrated, regional quality improvement program that linked the 35 spoke health care centers to the 4 large PCI hub hospitals and leveraged recent developments in public health insurance schemes, emergency medical services, and health information technology. Main Outcomes and Measures Primary outcomes focused on the proportion of patients undergoing reperfusion, timely reperfusion, and postfibrinolysis angiography and PCI. Secondary outcomes were in-hospital and 1-year mortality. Results A total of 2420 patients with STEMI (2034 men [84.0%] and 386 women [16.0%]; mean [SD] age, 54.7 [12.2] years) (898 in the preimplementation phase and 1522 in the postimplementation phase) were enrolled, with 1053 patients (43.5%) from the spoke health care centers. Missing data were common for systolic blood pressure (213 [8.8%]), heart rate (223 [9.2%]), and anterior MI location (279 [11.5%]). Overall reperfusion use and times to reperfusion were similar (795 [88.5%] vs 1372 [90.1%]; P = .21). Coronary angiography (314 [35.0%] vs 925 [60.8%]; P < .001) and PCI (265 [29.5%] vs 707 [46.5%]; P < .001) were more commonly performed during the postimplementation phase. In-hospital mortality was not different (52 [5.8%] vs 85 [5.6%]; P = .83), but 1-year mortality was lower in the postimplementation phase (134 [17.6%] vs 179 [14.2%]; P = .04), and this difference remained consistent after multivariable adjustment (adjusted odds ratio, 0.76; 95% CI, 0.58-0.98; P = .04). Conclusions and Relevance A hub-and-spoke model in South India improved STEMI care through greater use of PCI and may improve 1-year mortality. This model may serve as an example for developing STEMI systems of care in other low- to middle-income countries.
Collapse
Affiliation(s)
- Thomas Alexander
- Department of Cardiology, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India
| | - Ajit S Mullasari
- Department of Cardiology, Madras Medical Mission, Chennai, Tamil Nadu, India
| | - George Joseph
- Department of Cardiology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
| | - Kumaresan Kannan
- Department of Cardiology, Stanley Medical College and Hospital, Chennai, Tamil Nadu, India
| | - Ganesh Veerasekar
- Department of Clinical Epidemiology, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India
| | - Suma M Victor
- Department of Cardiology, Madras Medical Mission, Chennai, Tamil Nadu, India
| | - Colby Ayers
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas
| | - Viji Samuel Thomson
- Department of Cardiology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India
| | - Vijayakumar Subban
- Department of Cardiology, Madras Medical Mission, Chennai, Tamil Nadu, India
| | - Justin Paul Gnanaraj
- Department of Cardiology, Stanley Medical College and Hospital, Chennai, Tamil Nadu, India
| | - Jagat Narula
- Division of Cardiology, Icahn School of Medicine, Mount Sinai Hospital, New York, New York
| | - Dharam J Kumbhani
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas
| | - Brahmajee K Nallamothu
- Department of Internal Medicine and Michigan Center for Health Analytics and Medical Prediction, University of Michigan, Ann Arbor
| |
Collapse
|
6
|
Sinha SS, Prabhakaran D, Chopra V. Confluence of Cultural Context and Technological Innovation to Reduce Cardiovascular Disparities in India. Circ Cardiovasc Qual Outcomes 2017; 10:CIRCOUTCOMES.117.004081. [PMID: 29101271 DOI: 10.1161/circoutcomes.117.004081] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Shashank S Sinha
- From the Division of Cardiovascular Medicine, Samuel and Jean Frankel Cardiovascular Center (S.S.S.) and Division of General Medicine (V.C.), Michigan Medicine, Ann Arbor; Michigan Integrated Center for Health Analytics and Medical Prediction, Institute for Healthcare Policy and Innovation (S.S.S.), and Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (V.C.), University of Michigan, Ann Arbor; Patient Safety Enhancement Program, Division of Hospital Medicine, University of Michigan Health System, Ann Arbor (V.C.); Centre for Chronic Disease Control, Gurgaon, India (D.P.); Centre for Control of Chronic Conditions, Public Health Foundation of India, Gurgaon, India (D.P.); and London School of Hygiene and Tropical Medicine, London, United Kingdom (D.P.).
| | - Dorairaj Prabhakaran
- From the Division of Cardiovascular Medicine, Samuel and Jean Frankel Cardiovascular Center (S.S.S.) and Division of General Medicine (V.C.), Michigan Medicine, Ann Arbor; Michigan Integrated Center for Health Analytics and Medical Prediction, Institute for Healthcare Policy and Innovation (S.S.S.), and Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (V.C.), University of Michigan, Ann Arbor; Patient Safety Enhancement Program, Division of Hospital Medicine, University of Michigan Health System, Ann Arbor (V.C.); Centre for Chronic Disease Control, Gurgaon, India (D.P.); Centre for Control of Chronic Conditions, Public Health Foundation of India, Gurgaon, India (D.P.); and London School of Hygiene and Tropical Medicine, London, United Kingdom (D.P.)
| | - Vineet Chopra
- From the Division of Cardiovascular Medicine, Samuel and Jean Frankel Cardiovascular Center (S.S.S.) and Division of General Medicine (V.C.), Michigan Medicine, Ann Arbor; Michigan Integrated Center for Health Analytics and Medical Prediction, Institute for Healthcare Policy and Innovation (S.S.S.), and Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (V.C.), University of Michigan, Ann Arbor; Patient Safety Enhancement Program, Division of Hospital Medicine, University of Michigan Health System, Ann Arbor (V.C.); Centre for Chronic Disease Control, Gurgaon, India (D.P.); Centre for Control of Chronic Conditions, Public Health Foundation of India, Gurgaon, India (D.P.); and London School of Hygiene and Tropical Medicine, London, United Kingdom (D.P.)
| |
Collapse
|